Drugs Made In America Acquisition Corp. (DMAAU) Shares Outstanding (2024 - 2025)
Drugs Made In America Acquisition's (DMAAU) quarterly Shares Outstanding (Entity) came in at $21.0 million in Q4 2025, up 113.13% YoY from $9.9 million in Q4 2024, and down 8.66% on a QoQ basis from $23.0 million in Q3 2025.
Drugs Made In America Acquisition Corp. (DMAAU) Shares Outstanding (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMAAU) has 2 years of Shares Outstanding (Entity) data on file, last reported at $21.0 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 113.13% year-over-year to $21.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.0 million (up 113.13% YoY) and the FY2025 annual result came in at $21.0 million, up 113.13% from the prior year.
- Shares Outstanding (Entity) fell to $21.0 million in Q4 2025, from $23.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $23.0 million in Q2 2025 to a low of $9.9 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.01 Mn |
| Sep 30, 2025 | 23.00 Mn |
| Jun 30, 2025 | 23.00 Mn |
| Mar 31, 2025 | 15.18 Mn |
| Dec 31, 2024 | 8.57 Mn |